Search
Search Results
Found 3 items.
-
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience
Published: December 31, 20171436PDF: 752 -
How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice
Published: September 26, 2022555PDF: 284 -
Adverse pathological outcomes of patients with de novo muscle invasive bladder cancer in Northern Ontario
Published: March 29, 20221049PDF: 344
1 - 3 of 3 items